搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
C&EN
9 小时
Dueling glue degraders take on sickle cell disease
BMS isn’t the only firm trying to use degraders to tackle sickle cell disease. Novartis has a Wiz-targeting glue degrader, ...
12 小时
Beam Therapeutics Unveils New Safety, Efficacy Data From Sickle Cell Disease Candidate ...
Beam Therapeutics Inc. (NASDAQ:BEAM) revealed new safety and efficacy data from its BEACON Phase 1/2 trial of BEAM-101 in ...
2 天
on MSN
A sickle cell first: Base editing, a new form of gene therapy, leaves patient feeling 'more ...
Though he doesn't remember it, Branden Baptiste had his first sickle cell crisis at age 2. Through elementary school, he was ...
16 小时
ASH24: Darzalex in smoldering myeloma, Merck’s ADC data and Novo’s sickle cell drug
J&J aims to expand Darzalex's use even further in the blood cancer, while Merck & Co. and Novo Nordisk presented at ASH ...
Everyday Health on MSN
3 天
Sickle Cell Anemia Symptoms
The hallmark symptom of sickle cell anemia is pain, particularly episodes of sudden pain, sometimes called sickle cell crises ...
18 小时
Life-changing gene therapy to help local siblings
When you give to Light Up A Lawn, Light Up A Life, you are supporting programs like Nationwide Children's cutting-edge gene ...
15 小时
Beam Therapeutics Advances BEAM-101 Therapy for Sickle Cell
The latest announcement is out from Beam Therapeutics ( (BEAM) ).
STAT
2 天
Sanofi advances a drug for a rare, platelet-destroying disease
A drug developed by Sanofi raised platelet counts and reduced bleeding episodes in patients with a rare autoimmune disorder ...
11 小时
Editas Medicine reports updated clinical data from RUBY trial of Reni-cel
Editas Medicine (EDIT) will present updated safety and efficacy data in 28 patients living with severe sickle cell disease treated with ...
2 天
MiNA Therapeutics Presents New Pre-Clinical Data from Lead Sickle Cell Disease Program at ...
MiNA Therapeutics Limited, the pioneer in small activating RNA (RNAa) therapeutics, today presented new pre-clinical data for its lead RNA activation program for the treatment of sickle cell disease, ...
Armed robbery in Revesby
2 天
Sickle Cell Breakthrough: Base Editing Success
Though he doesn't remember it, Branden Baptiste had his first sickle cell crisis at age 2. Through elementary school, he was ...
TipRanks on MSN
1 天
Beam presents new NHP data demonstrating proof-of-concept for ESCAPE
Beam Therapeutics (BEAM) announced new data for its Engineered Stem Cell Antibody Evasion, or ESCAPE, conditioning platform.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈